The Orange Book codes are the FDA’s therapeutic equivalence ratings for multi-source drugs, where “A” codes indicate bioequivalence and “B” codes indicate unresolved bioequivalence issues as of 2026.
What is a TE code?
A TE code is a 2-letter therapeutic equivalence code used in the FDA’s Orange Book to indicate whether a generic drug is therapeutically equivalent to its reference product as of 2026.
Now, TE codes appear as two-letter combinations (e.g., AB, AA, AN) - and they inform pharmacists and prescribers whether a generic can be substituted for a brand-name drug without clinical difference. Generally, the FDA assigns these codes based on rigorous bioequivalence testing and formulation analysis. Each code corresponds to a specific therapeutic equivalence evaluation standard laid out in the Orange Book’s Approved Drug Products with Therapeutic Equivalence Evaluations. Honestly, matching TE codes between a generic and its reference listed drug (RLD) is essential for safe substitution in pharmacy practice.
What does Orange Book code ZC mean?
Orange Book code ZC identifies products that do not have a therapeutic equivalence rating, typically single-source drugs without a generic alternative as of 2026.
ZC-rated drugs are not eligible for generic substitution - because their bioequivalence has not been established or they are protected by exclusivity. These products are often newly approved or have complex delivery systems that prevent generic duplication. (That's why they're not substitutable.) The FDA includes ZC codes in the Orange Book to signal that no therapeutically equivalent generic exists. Always consult a healthcare provider before switching from a ZC-rated drug to avoid therapeutic failure or adverse events.
What does AB1 and AB2 mean?
AB1 and AB2 indicate therapeutic equivalence to specific reference drugs, where AB1 generics match the AB1-rated reference, and AB2 generics match the AB2-rated reference as of 2026.
The numeric suffix (1 or 2) refers to different formulations, salt forms, or dosage forms of the same active ingredient that have been separately evaluated by the FDA. For example, AB1 might correspond to a specific extended-release formulation, while AB2 refers to an immediate-release version. It’s critical to match both the AB rating and the numeric suffix to the specific RLD to ensure clinical interchangeability. This precision prevents dosing errors and maintains therapeutic consistency, especially in drugs with narrow therapeutic indices. Here's the thing: this level of detail is what makes the Orange Book so useful.
What is a patent use code?
A patent use code in the Orange Book tells how an NDA holder’s method patent relates to the approved drug’s indications or formulations as of 2026.
Patent use codes clarify whether a patent covers the use of the drug for a specific indication, a particular formulation, or a method of treatment. Common codes include “U-1234” for use patents and “P-5678” for formulation patents. These codes help generic manufacturers avoid patent infringement when developing bioequivalent products. They are listed in the Orange Book alongside drug patents and are essential for legal and regulatory clarity in drug development. Typically, you'll want to review patent use codes when assessing generic competition timelines.
What is an AB rated drug?
An AB rated drug has resolved bioequivalence issues through in vivo or in vitro testing and is considered therapeutically equivalent to its reference listed drug as of 2026.
AB ratings are the FDA’s highest confidence rating for generic substitution. Drugs rated AB have passed comparative pharmacokinetic studies demonstrating that the generic delivers the same amount of active ingredient to the bloodstream as the brand-name version. This equivalence ensures that switching from a brand to an AB-rated generic will not alter therapeutic outcomes. The AB rating appears in the Orange Book under the therapeutic equivalence section for each drug entry. Pharmacists rely on AB ratings to safely substitute generics unless the prescriber specifies “dispense as written.” That said, it's always a good idea to double-check the AB rating.
What is a pharmacologic alternative?
A pharmacologic alternative contains the same active ingredient but may differ in dosage form, strength, salt, or ester as of 2026.
These alternatives are chemically related but not necessarily bioequivalent to the original product. For example, erythromycin base and erythromycin stearate are pharmacologic alternatives used to treat similar infections. Unlike therapeutic alternatives, pharmacologic alternatives are not automatically substitutable. A pharmacist or physician must evaluate the clinical appropriateness of switching between them. Differences in solubility, absorption, or metabolism can affect efficacy or side effects. Always confirm with a healthcare provider before substituting a pharmacologic alternative - it's just safer that way.
How do you cite the Orange Book?
To cite the Orange Book, use the APA format: U.S. Food and Drug Administration. (Year). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (Publication No. X).
Example citation: FDA. (2026). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Department of Health and Human Services. The Orange Book is updated annually, so always include the edition year. If referencing a specific drug entry, include the drug name and TE code in the text. For legal or regulatory documents, a Bluebook citation may be preferred. Generally, it's a good idea to check the most recent edition and update your citation accordingly.
What is an A rated drug?
An A rated drug is therapeutically equivalent to its reference listed drug, confirmed by bioequivalence studies as of 2026.
A rated drugs form the foundation of safe generic substitution in the U.S. healthcare system. The FDA assigns an “A” rating only after rigorous testing proves that the generic performs identically to the brand in both rate and extent of absorption. This rating appears in the Orange Book as “A” or “AA,” with further subdivisions indicating formulation-specific equivalence. Drugs rated “A” are listed under Part II of the Orange Book, which covers therapeutic equivalence evaluations. Typically, you'll want to verify the A rating before making any substitution, especially for drugs with critical dosing requirements.
What is the Orange Book used for?
The Orange Book identifies FDA-approved drugs, their therapeutic equivalence ratings, and patent information to guide generic substitution and clinical decisions as of 2026.
Originally titled “Approved Drug Products with Therapeutic Equivalence Evaluations,” the Orange Book is a public resource maintained by the FDA. It helps pharmacists identify which generics can be safely substituted for brand-name drugs without altering clinical outcomes. The Orange Book also lists drug patents and exclusivity periods, which are critical for determining when generic versions can enter the market. Hospitals, insurers, and prescribers use it to make evidence-based decisions about drug therapy. The book is updated monthly and available online via the FDA’s Orange Book database. Now, regular updates ensure that clinicians have access to the most current therapeutic and legal information.
What is bio equivalence?
Bioequivalence means a generic drug delivers the same amount of active ingredient to the bloodstream at the same rate as the brand-name reference product as of 2026.
To be considered bioequivalent, a generic must meet strict FDA criteria: its active ingredient must be absorbed within 80–125% of the reference product’s rate and extent of absorption. This standard ensures that the generic is as safe and effective as the brand. Bioequivalence testing involves pharmacokinetic studies in healthy volunteers, comparing drug concentration curves over time. Some drugs, like narrow therapeutic index drugs, require additional in vivo testing to confirm bioequivalence. Generally, you'll want to confirm a drug’s bioequivalence status by checking its TE code in the Orange Book before substitution.
What is AB1 Orange Book rating?
The AB1 Orange Book rating indicates a generic drug is therapeutically equivalent to a specific AB1-rated reference listed drug with the same formulation or salt form as of 2026.
AB1 ratings apply to generics that match a reference product with the same active ingredient, dosage form, strength, and salt form. The “1” suffix distinguishes it from AB2, which may correspond to a different formulation (e.g., extended-release vs. immediate-release). AB1-rated generics are fully substitutable for their AB1 reference in pharmacy practice. The Orange Book lists AB1 ratings under the therapeutic equivalence section, making it easy to verify interchangeability. This precision ensures that patients receive the exact formulation intended by their prescriber. Honestly, it's a crucial aspect of ensuring patient safety.
How do I find a drug patent?
You can find a drug patent by searching the Orange Book’s patent section using the drug’s active ingredient or trade name as of 2026.
Start with the FDA’s Orange Book database, then navigate to the patent section for your drug. Enter either the generic or brand name to view listed patents, expiration dates, and patent use codes. Each patent entry includes the patent number, expiration date, and the specific use it covers (e.g., formulation, method of use). If a drug isn’t listed in the Orange Book, it may be a new molecular entity or not yet approved. For unapproved drugs, check the Google Patents database or the FDA’s Drugs@FDA portal. Now, that should give you a good starting point for your search.
What is RLD and RS in Orange Book?
RLD (Reference Listed Drug) is the brand-name drug used as the standard for bioequivalence testing, while RS (Reference Standard) refers to the active ingredient used in comparative studies as of 2026.
Every generic drug must demonstrate bioequivalence to an RLD to receive an AB rating. The RLD is typically the original brand-name product approved by the FDA. The RS, on the other hand, is the active pharmaceutical ingredient used in laboratory testing to confirm equivalence. Both RLD and RS are specified in the Orange Book under each drug’s entry. The RLD serves as the benchmark for therapeutic equivalence, while the RS ensures consistency in testing across formulations. Generally, understanding the difference between RLD and RS is essential for navigating the Orange Book.
Where can I find drug patents?
Drug patents can be found in the FDA’s Orange Book, Drugs@FDA database, or the USPTO’s patent search tools as of 2026.
Begin with the FDA Orange Book, which lists patents for approved drugs alongside their expiration dates and use codes. For unapproved or investigational drugs, use the Drugs@FDA database. The U.S. Patent and Trademark Office (USPTO) also provides patent details, including expiration dates and claims. Always cross-check patent information across sources, as patents can be listed with varying degrees of specificity. If you’re researching a drug’s exclusivity period, the Orange Book provides the most reliable summary. That said, it's always a good idea to verify patent information through multiple sources.
